Concepedia

Mohammad Alyamani

MA

16

Publications

940

Citations

16

H-Index

2015

Active since

Affiliations

Cleveland Clinic Lerner College of Medicine(Current)

Cleveland Clinic

Harvard University

Dana-Farber Cancer Institute

University of Michigan

Mohammad Alyamani is an author at Cleveland Clinic Lerner College of Medicine specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2015–2023

16

Publications

16

Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer

Zhenfei Li, Andrew C. Bishop, Mohammad Alyamani et al. · Nature · 2015 · 251 citations · Full text

, , +7

Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy

Zhenfei Li, Mohammad Alyamani, Jianneng Li et al. · Nature · 2016 · 165 citations · Full text

, , +5

Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer

Jianneng Li, Mohammad Alyamani, Ao Zhang et al. · eLife · 2017 · 123 citations · Full text

, , +16

HSD3B1(1245A>C) variant regulates dueling abiraterone metabolite effects in prostate cancer

Mohammad Alyamani, Hamid Emamekhoo, Sunho Park et al. · Journal of Clinical Investigation · 2018 · 52 citations · Full text

Steroidogenic Metabolism of Galeterone Reveals a Diversity of Biochemical Activities

Mohammad Alyamani, Zhenfei Li, Michael Berk et al. · Cell chemical biology · 2017 · 45 citations · Full text

, , +7

Rows per page

1–5 of 16